Medtronic has released a new insulin pump/continuous glucose monitoring system, called Paradigm Veo, that features intelligent protection against episodes of hypoglycemia when the patient is ignoring the dropping sugar levels. After alerting the wearer of an oncoming event, the Paradigm Veo system automatically stops the insulin pump if the patient does not act on the warning. The system is now available for sale to much of the world, but Medtronic is still awaiting FDA clearance to market in the United States.
The Paradigm Veo System includes an insulin pump with a continuous glucose monitoring (CGM) system (provided by means of a separate sensor and transmitter). The patient uses readings from the monitor in conjunction with occasional confirmatory fingerstick blood glucose measurements to understand their current glucose level. Based on these results, the patient then programs the insulin pump to deliver an appropriate amount of insulin. Insulin combats high blood sugar, a key cause of heart disease and other long-term complications in type 1 diabetes.1 However, if data transmitted from the sensor show the patient’s glucose levels have dropped below a defined threshold, the device alarms to alert the patient. If these alarms are ignored, the insulin pump automatically suspends insulin delivery for up to two hours. This helps to protect against potentially dangerous hypoglycemic events.
The Paradigm Veo is equipped with a Low Glucose Suspend18 (LGS) mechanism, which will halt insulin delivery automatically whenever your glucose levels are too low. This can help to reduce the risk of severe hypoglycaemia. And being a CGM-Ready pump, the Paradigm Veo system can offer you the advanced insight of Continuous Glucose Monitoring19 as well. Giving you all the information you need to make the right decisions:
- Monitoring and recording your glucose levels 24/7
- Allowing you to identify trends and make appropriate adjustments to your lifestyle/treatment
- Warning you when your glucose levels stray from your target range
Press release: New Diabetes Device May Be Next Step in Quest for Artificial Pancreas…
Product page: Paradigm Veo…
